Why Caribbean Health Is Invisible to the Investors Looking for It

Last year, global healthcare private equity investment reached a record $191 billion in total deal value as published in a recent Bain and Company Healthcare PE report.

The entire Caribbean healthcare sector, across 200 companies and since inception, has raised $26.5 million in combined venture and private equity funding.

I want to spend this edition explaining why I do not think that gap is primarily a quality story.

THE QUALITY IS THERE

Caribbean private health has real assets. There are hospitals in this region with occupancy rates, revenue trajectories, and patient loyalty that would attract serious investor attention in any other market. There are physician practices with genuine clinical differentiation and service mixes that fill real gaps in underserved communities. There are emerging digital health businesses addressing problems that are specific to Caribbean disease profiles and patient behaviour.

The quality, in many cases, is there.

What is not there is legibility.

THE LEGIBILITY PROBLEM

Investors do not find what they cannot read. Most Caribbean private health businesses, even the genuinely good ones, are not built to be read by external capital.

Audited financials are the baseline. Not management accounts. Not a spreadsheet the owner updates monthly. Audited financials for at least three years, prepared by a firm with enough standing that an investor can rely on them.

I found myself at one time, reviewing an opportunity to acquire a distressed hospital asset and had to beg to review financial data, but also needed extensive explanation of the P & L and balance sheets. Things were vague, costs not forthcoming and you could just tell, something was not right.

Most Caribbean private health businesses do not have these as detailed or as clear as investors need. Not because the revenues are not real. Because the financial hygiene that makes them verifiable has never been a priority.

Beyond financials, governance documentation matters. A corporate structure that is clean and understandable. Decision-making processes that exist on paper. A board or advisory structure that shows the business can be led by more than one person.

And beyond governance, value articulation. The ability to explain, clearly and without the owner in the room, what this institution does that others do not, what its patient outcomes look like measured against a reasonable benchmark, and why those advantages are defensible over a five-year investment horizon.

Most Caribbean health business owners have never been asked to answer those questions in writing. So they have never prepared written answers. I have started challenging my owner-colleagues to do this in their institutions.

THE OPPORTUNITY THIS CREATES

PwC's 2026 healthcare investment outlook identifies Physician Practice Management as a sector where deal activity is expected to resume after years of stalled transactions. The model that has driven value creation in North American and European specialty medicine, properly governed multi-specialty platforms with integrated technology and clear clinical metrics, does not yet exist in the Caribbean.

That absence is an opportunity for the first serious operator who builds it correctly.

The patient volume is there. The disease burden, dominated by NCDs that require longitudinal management, creates genuine demand for a well-structured primary and specialty care platform. The physician talent exists across the region.

What does not yet exist is the institutional infrastructure that makes the opportunity legible to the capital that is actively looking for exactly this kind of asset.

WHAT THIS MEANS FOR CARIBBEAN HEALTH LEADERS?

The preparation for investor visibility is not a transaction exercise. It is an institutional discipline.

Clean financial reporting. Proper governance structures. Measurable clinical outcomes. A value proposition that holds up without the founder in the room to explain it.

These are the things that make a health institution investor-ready. They are also, not coincidentally, the things that make it better for patients and staff every day, regardless of whether a transaction ever happens.

The $191 billion will keep moving through the global healthcare sector. The Caribbean institutions that are building the infrastructure to receive it will be the ones that benefit when the conversation finally arrives.

Dr. Christopher Bristo is an FRCP(UK) physician-executive and healthcare strategist based in Trinidad and Tobago. He advises Caribbean health systems, private hospitals, and healthcare investors on governance, transformation, and investment positioning.

trevorkensington.com